Chong Xian Pan, MD, PhD, Harvard Medical School, Boston, MA, discusses improving the efficacy of immunotherapy in bladder cancer. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть